Beam Therapeutics BEAM Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Business | ||||||
| Employee Related Expenses | $120.99M+16.9% | $117.37M+18.8% | $111.8M+13.0% | $108.07M+5.4% | $103.47M-3.3% | |
| External Research And Development Expenses | $138.35M+11.3% | $142.69M+23.9% | $140.08M+15.1% | $139.93M+10.1% | $124.25M-12.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Beam Therapeutics break its business down?
- Beam Therapeutics (BEAM) reports research and development expense by business across 2 parts — Employee Related Expenses and External Research And Development Expenses. Each is extracted from the segment footnotes and tracked over time.
- Where does Beam Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Beam Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.